Skip to the page

Data / Medical devices / South Korea / Oncosoft Inc.

Oncosoft Inc.: FDA-registered device maker in Seoul, South Korea, 2 510(k) clearances

Oncosoft Inc. is registered with the FDA (registration 3036758982) in Seoul, South Korea. It lists 1 device type. The FDA files 2 510(k) clearances under its listings, the newest dated July 2, 2026. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3036758982
Address
37 Myeongmul-gil Seodaemun-gu, Seoul, South Korea, 03776
Owner or operator
Oncosoft Inc. (10092859)
Roles
Complaint file establishment, Exporter to the US, Manufacturer
First device listed
February 27, 2025
Registered through
2026
Brand names listed
OncoStudio

Devices it lists

DeviceProduct codeClassRoleSource
Radiological Image Processing Software For Radiation TherapyQKB2Complaint file establishment, Exporter to the US, Manufactureraccessdata.fda.gov

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
July 2, 2026K260528OncoStudioQKBSubstantially EquivalentOncosoft. Inc.,accessdata.fda.gov
February 24, 2025K242994OncoStudio (OS-01)QKBSubstantially EquivalentOncosoft. Co., Ltd.accessdata.fda.gov

Compare with other makers

Updated July 2, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.